MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR

Clinical trial NCT06139094 · COMPLETED

Trial details

NCT number: NCT06139094
Sponsor: Genetesis Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Ischemic Heart Disease Coronary Microvascular Disease Angina

Start date: 2023-12-20
Primary completion: 2024-05-13
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.